Symmetry Medical Reports First Quarter 2010 Financial Results
First Quarter 2010 Highlights:
- Revenue increased 11% over fourth quarter 2009
- Operating income increased 225% over fourth quarter 2009
- Increases low end of revenue and EPS guidance range; reaffirms high end of ranges
PR Newswire
WARSAW, Ind., May 6
WARSAW, Ind., May 6 /PRNewswire-FirstCall/ -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced first quarter 2010 financial results for the three-month period ended April 3, 2010.
First Quarter | Vs Prior Quarter | ||||||
(in millions, except share data) | 2010 | 2009 | Change | 1Q'10 | 4Q'09 | Change | |
Revenue | $84.5 | $101.4 | -17% | $84.5 | $76.4 | 11% | |
Operating Income | 3.9 | 11.2 | -65% | 3.9 | 1.2 | 225% | |
Net Income | 1.6 | 6.8 | -76% | 1.6 | 0.6 | 167% | |
EPS | $0.05 | $0.19 | -74% | $0.05 | $0.02 | 150% | |
Non-GAAP* | |||||||
Operating Income* | 4.4 | 11.3 | -61% | 4.4 | 3.1 | 42% | |
Net Income* | 2.0 | 6.9 | -71% | 2.0 | 1.8 | 11% | |
EPS* | $0.06 | $0.19 | -68% | $0.06 | $0.05 | 20% | |
Revenue by Product: | |||||||
Instruments | $33.4 | $46.5 | -28% | $33.4 | $32.0 | 4% | |
Implants | 28.2 | 29.1 | -3% | 28.2 | 24.8 | 14% | |
Cases | 17.0 | 18.5 | |||||
